IMMUCELL CORP /DE/ (ICCC) › Shareholders' EquityIMMUCELL CORP /DE/ (ICCC) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2008: $9.64M2009: $9.62M2010: $9.28M2011: $9.02M2012: $9.19M2013: $9.40M2014: $9.26M2015: $10.61M2016: $19.72M2017: $23.59M2018: $21.74M2019: $28.99M2020: $28.27M2021: $32.58M2022: $30.38M2023: $24.99M2024: $27.52M2025: $27.06M$27.06M2008Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$27.06M-1.7%2024$27.52M+10.1%2023$24.99M-17.7%2022$30.38M-6.7%2021$32.58M+15.3%2020$28.27M-2.5%2019$28.99M+33.3%2018$21.74M-7.8%2017$23.59M+19.6%2016$19.72M+85.8%2015$10.61M+14.6%2014$9.26M-1.5%2013$9.40M+2.2%2012$9.19M+1.9%2011$9.02M-2.8%2010$9.28M-3.5%2009$9.62M-0.2%2008$9.64M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share